Technical Analysis for SBIO - ALPS Medical Breakthroughs ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | -5.30% | |
| Multiple of Ten Bearish | Other | -5.30% | |
| Down 3 Days in a Row | Weakness | -5.30% | |
| Volume Surge | Other | -8.08% |
| Alert | Time |
|---|---|
| Down 2 ATRs | 1 day ago |
| 2x Volume Pace | 2 days ago |
| 1.5x Volume Pace | 2 days ago |
| 3x Volume Pace | 2 days ago |
| Down 3% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM.
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
Classification
Keywords: Exchange Traded Fund ETF Index Fund Biotechnology Pharmaceutical Passive Management
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 42.73 |
| 52 Week Low | 24.9616 |
| Average Volume | 7,845 |
| 200-Day Moving Average | 35.78 |
| 50-Day Moving Average | 38.41 |
| 20-Day Moving Average | 39.40 |
| 10-Day Moving Average | 40.16 |
| Average True Range | 0.97 |
| RSI (14) | 38.65 |
| ADX | 20.45 |
| +DI | 27.49 |
| -DI | 43.66 |
| Chandelier Exit (Long, 3 ATRs) | 39.83 |
| Chandelier Exit (Short, 3 ATRs) | 39.88 |
| Upper Bollinger Bands | 42.20 |
| Lower Bollinger Band | 36.61 |
| Percent B (%b) | 0.07 |
| BandWidth | 14.20 |
| MACD Line | 0.37 |
| MACD Signal Line | 0.60 |
| MACD Histogram | -0.2334 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 39.41 | ||||
| Resistance 3 (R3) | 39.68 | 39.14 | 39.01 | ||
| Resistance 2 (R2) | 39.14 | 38.52 | 39.01 | 38.87 | |
| Resistance 1 (R1) | 38.06 | 38.14 | 37.79 | 37.79 | 38.73 |
| Pivot Point | 37.52 | 37.52 | 37.38 | 37.38 | 37.52 |
| Support 1 (S1) | 36.44 | 36.90 | 36.17 | 36.17 | 35.22 |
| Support 2 (S2) | 35.90 | 36.52 | 35.76 | 35.09 | |
| Support 3 (S3) | 34.82 | 35.90 | 34.95 | ||
| Support 4 (S4) | 34.55 |
